Significantly to the recent energy-saving environmental protection industry policy, clean energy industry tilt, which has become the new energy environment protection and energy sector and continued strength of the base plate. Biopharmaceutical policy is also focused on supporting the industry, Eleventh Five Year Plan proposes to accelerate the development and the development of biotechnology industry; in the Investors may focus on the performance of the inflection point, the fund focus on cutting-edge 000,661 Masukura the Changchun High-tech bio-medicine.
Changchun High-tech (000 661): As the business manager of Changchun High Technology Development Zone, the company recognized early on the property lease management business limitations. use their own high-tech development zone enterprises know too much advantage,Bailey UGG boots, the company started to invest from 10 years ago, bio-pharmaceutical industry. subsidiary of growth hormone Kinsey first brand of Chinese medicine has There are 6 major genetic engineering drugs on the market, 8 exclusive new genetically engineered drugs are being developed. Kinsey medicine world-class technology and quality products; new formulations, new indications continue to expand; both built on the core R & D infrastructure ahead on the advantage of existing and potential competitors in the domestic. Since the overall time to promote domestic growth hormone on the market late, and in relation to competitors, EPO, interferon and other drugs in terms of fewer genes, the company has 6 years maintain an average annual growth of 60% of high performance.
company also owns two major breakthroughs in this biotech company. Changchun Sparks medicine and the internationally renowned Johns Hopkins University, under the vital research and development companies in Asia type of AIDS vaccine, vital company has years of experience in AIDS vaccine research and development,UGG shoes, which the company has a leading scientific research strength, has now completed Phase I clinical summary and II clinical preparations, is awaiting government approval documents II clinical trial. China is attention to AIDS prevention and control, formulated . one hundred grams medicine in clinical research as the only domestic firms have access to state subsidies. In addition, one hundred grams of biological chicken pox, hepatitis A vaccine is also expected to receive approval, the market is vast.'s recent acquisition of biological abundance is the second step house technical training to use the micro-containing rabies vaccine in VERO cell production of domestic enterprises. rabies incidence and mortality in China has been high, but the domestic production of rabies vaccine in the original technology need to add adjuvants, affect the efficacy and efficiency without adjuvant Pasteur rabies vaccine market has been in China and other foreign companies accounted for the implementation of .2006 rabies vaccine without adjuvant,UGG boots cheap, resulting in continued strong demand for rabies vaccine. rabies vaccine market is currently a big shortfall, Mai Feng biological program completed during the year GMP certification,UGG boots clearance, the new products will be the market in 2008, became the company's new profit growth point. Since the broader market slump since the formation of a convergence of the stock order form a triangle, when the stock plummeted on Wednesday against the market trend in the broader market strength, the possibility of breaking up the large, investors can focus on.
No comments:
Post a Comment